volume 15 • issue 2 • february 2021 issn 1814 3601...lao people's democratic republic 3 0.4...

Volume 15 • Issue 2 • February 2021 ISSN 1814 3601

Figure 1. Incidence rate of measles cases with rash onset 1–31 January 2021, WHO Western Pacific Region

Pacific island countries and areas

DISCLAIMER: The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO Regional Office for the Western Pacific 2021. All rights reserved *Map of Australia is from the Australian Bureau of Statistics

Table 1. Numbers of confirmed and total (confirmed and compatible) measles cases by month of rash onset, August 2020–January 2021, WHO Western Pacific Region

Source: Measles and rubella monthly country reports to the Western Pacific Regional Office by 20 February 2021

No. of confirmed

Total no. of cases

No. of confirmed

Total no. of cases

No. of confirmed

Total no. of cases

No. of confirmed

Total no. of cases

No. of confirmed

Total no. of cases

No. of confirmed

Total no. of cases

Australia1 0 0 0 0 0 0 0 0 0 0 0 0Brunei Darussalam 0 0 0 0 0 0 0 0 0 0 0 0Cambodia 1 1 4 4 5 5 1 1 0 0 4 4China 77 78 66 66 71 75 78 83 49 52 28 36China, Hong Kong SAR 0 0 0 0 0 0 0 0 0 0 0 0China, Macao SAR 0 0 0 0 0 0 0 0 0 0 0 0Japan 0 0 1 1 0 0 0 0 0 0 0 0Lao People's Democratic Republic 0 0 2 2 0 0 0 0 1 1 0 0Malaysia 28 28 11 11 19 20 17 17 16 16 7 8Mongolia 0 0 0 0 0 0 0 0 0 0 0 0New Zealand 0 0 0 0 0 0 0 0 0 0 0 0Papua New Guinea 0 0 1 1 0 0 0 0 0 0 0 0Philippines 4 46 1 31 0 17 1 28 2 17 2 44Republic of Korea 0 0 0 0 0 0 0 0 0 0 0 0Singapore 0 0 0 0 2 2 0 0 0 0 0 0Viet Nam 0 24 6 48 19 51 3 39 0 8 0 3Pacific island countries and areas 0 0 0 0 0 0 0 0 0 0 0 0Western Pacific Region 110 177 92 164 116 170 100 168 68 94 41 951 Reports only confirmed cases"-" No data

Dec2020 2021

JanAug Sep Oct NovCountry/area


Figure 2. Total (confirmed and compatible) measles cases by month of rash onset, WHO Western Pacific Region, 2016–2021 as of 20 February 2021

0

2 000

4 000

6 000

8 000

10 000

12 000

14 000

16 000

18 000Ja

nFe

bM

ar Apr

May Jun Jul

Aug

Sep

Oct

Nov

Dec

Jan

Feb

Mar Apr

May Jun Jul

Aug

Sep

Oct

Nov

Dec

Jan

Feb

Mar Apr

May Jun Jul

Aug

Sep

Oct

Nov

Dec

Jan

Feb

Mar Apr

May Jun Jul

Aug

Sep

Oct

Nov

Dec

Jan

Feb

Mar Apr

May Jun Jul

Aug

Sep

Oct

Nov

Dec

Jan

2016 2017 2018 2019 2020 2021

Num

ber o

f mea

sles

cas

es

China Malaysia Mongolia Papua New Guinea Philippines Viet Nam Others

Source: Measles and rubella monthly country reports to WHO by 20 February 2021

Table 2. Status of verification of measles elimination, WHO Western Pacific Region


Imported Import-related Endemic

Unknown/ not

reportedImported Import-

related EndemicUnknown

/ not reported

Australia 2014 25 12 4 0 9 64.0% 0 - - - - -Brunei Darussalam 2015 0 - - - - - 0 - - - - -Cambodia 2015 372 0 0 0 372 0.0% 4 0 0 0 4 0.0%China - 829 0 0 0 893 0.0% 28 0 0 0 28 0.0%China, Hong Kong SAR 2016 1 0 0 0 1 0.0% 0 - - - - -China, Macao SAR 2014 0 - - - - - 0 - - - - -Japan 2015 11 3 1 0 7 36.4% 0 - - - - -Lao People's Democratic Republic - 132 0 0 0 132 0.0% 0 - - - - -Malaysia - 456 1 0 402 53 88.4% 7 0 0 5 2 71.4%Mongolia - 0 - - - - - 0 - - - - -New Zealand 2017 7 1 3 0 3 57.1% 0 - - - - -Papua New Guinea - 3 0 0 0 3 0.0% 0 - - - - -Philippines - 955 54 0 664 237 75.2% 2 0 0 2 0 100.0%Republic of Korea 2014 6 6 0 0 0 100.0% 0 - - - - -Singapore 2018 12 2 0 0 10 16.7% 0 - - - - -Viet Nam - 342 0 0 0 342 0.0% 0 - - - - -Pacific island countries and areas - 72 0 0 0 72 0.0% 0 - - - - -Total 3 223 79 8 1 066 2 134 35.8% 41 0 0 7 34 17.1%

Blue No measles casesGreen ≥80%Yellow 60–79%Red <60%

Country/area Year verified

2021

No. of confirmed

cases

Source of infection % of cases with known

source of infection

2020

No. of confirmed

cases

Source of infection % of cases with known

source of infection

2

3

Table 3. Measles case classification and incidence by country and area, WHO Western Pacific Region, 2017—2021 as of 20 February 2021

Clinically compatible Lab Epi-linked

Total confirmed

and clinically

compatible1

Annualized measles

incidence per

1 million pop.

Australia 81 3.3 101 4.1 285 11.3 25 1.0 25.8 NA3 - - - - - - - - 26-Feb-20

Brunei Darussalam 0 0.0 1 2.3 1 2.3 0 0.0 0.4 0 - - - - - - - - 13-Sep-19

Cambodia 10 0.6 3 0.2 676 41.0 372 22.3 16.9 101 51 46 0 4 0 4 2.8 0 24-Jan-21

China 5 993 4.2 3 975 2.8 3 098 2.2 867 0.6 1444.2 690 142 512 8 28 0 36 0.3 0 31-Jan-21

China, Hong Kong SAR 4 0.5 16 2.2 90 12.1 1 0.1 7.6 0 - - - - - - - - 24-Mar-20

China, Macao SAR 2 3.2 3 4.7 36 56.2 0 0.0 0.7 1 0 1 0 0 0 0 0.0 0 6-May-19

Japan 188 1.5 279 2.2 761 6.0 12 0.1 126.1 9 1 3 0 0 0 0 0.0 0 29-Sep-20

Lao People's Democratic Republic 3 0.4 10 1.4 1 119 156.1 135 18.6 7.4 30 26 4 0 0 0 0 0.0 0 11-Dec-20

Malaysia 1 693 54.4 1 958 62.1 1 077 33.7 467 14.4 32.8 155 94 53 1 7 0 8 2.9 0 17-Jan-21

Mongolia 9 2.9 1 0.3 2 0.6 0 0.0 3.3 0 - - - - - - - - 4-Mar-19

New Zealand 15 3.2 36 7.6 2 229 466.0 7 1.5 4.9 6 0 6 0 0 0 0 0.0 0 29-Jan-20

Papua New Guinea 7 0.8 15 1.7 1 0.1 4 0.4 9.1 1 0 1 0 0 0 0 0.0 0 7-Sep-20

Philippines 2 432 23.1 22 869 214.4 48 521 448.8 3 832 35.0 111.0 70 0 26 42 2 0 44 4.8 10 28-Jan-21

Republic of Korea 7 0.1 19 0.4 191 3.7 6 0.1 51.3 7 0 7 0 0 0 0 0.0 0 10-Feb-20

Singapore 81 14.2 37 6.4 162 27.9 14 2.4 5.9 0 - - - - - - - - 9-Oct-20

Viet Nam 592 6.3 1 249 13.1 5 004 51.9 713 7.3 98.2 71 67 1 3 0 0 3 0.4 0 4-Dec-20

Pacific island countries and areas4 2 0.6 0 0.0 6 346 1885.5 72 21.1 3.5 2 0 2 0 0 0 0 0.0 0 13-Jan-20

American Samoa - - - - 31 560.5 2 36.2 0.1 0 - - - - - - - - 19-Jan-20

Fiji 1 1.1 0 0.0 31 34.8 3 3.3 0.9 2 0 2 0 0 0 0 0.0 0 5-Mar-20

New Caledonia 1 3.6 0 0.0 0 0.0 - - 0.3 0 - - - - - - - - 10-Jan-17

Samoa - - - - 5 689 28864.5 18 90.7 0.2 0 - - - - - - - - 13-Jan-20

Solomon Islands 0 0.0 0 0.0 - - - - 0.7 0 - - - - - - - - 21-Jan-16

Tonga - - - - 608 5818.3 51 482.5 0.1 0 - - - - - - - - 13-Feb-20

Western Pacific Region 11 119 5.8 30 572 15.9 63 284 32.8 6 458 3.3 1949.0 1 143 381 662 54 41 0 95 0.6 101 Includes clinically compatible, laboratory confirmed and epi-linked confirmed cases Green <1 confirmed measles case / 1 000 000 population2 United Nations, Department of Economic and Social Affairs, Population Division World Population Prospects 2019 revision. Yellow 1–9.9 confirmed measles case / 1 000 000 population3 Australia reports confirmed cases only. Red >= 10 confirmed cases / 1 000 000 population4 Classification is provisional based on laboratory data only.

Country/area

2017

Total confirmed and

clinically compatible1

Measles incidence

per 1 million

pop.

2018 2019

Total confirmed

and clinically compatible1

Measles incidence

per 1 million

pop.

Total confirmed and

clinically compatible1

Measles incidence

per 1 million

pop.

Total confirmed

and clinically compatible1

Measles incidence per

1 million pop.

2021

Rash onset of last

confirmed measles

case

Population (in

millions) 2

Suspected measles

cases

Pending classification

Discarded cases3

Measles cases

Deaths due to measles

2020

3

4

Table 4. Measles surveillance performance indicators by country and area, WHO Western Pacific Region, 2020—2021 as of 20 February 2021

Discarded non-measles rate per

100 000 pop

Annualized discarded non-measles rate per

100 000 pop

≥ 2 ≥ 2

Australia 3 Insufficient data Insufficient data Insufficient data Insufficient data Insufficient data Insufficient data Insufficient data Insufficient data

Brunei Darussalam 4.3 Not applicable 94.7% 68.4% 0.0 Not applicable - -

Cambodia 13.3 100.0% 93.2% 98.5% 3.3 20.0% 97.0% 100.0%

China 2.0 32.3% 101.5% 96.1% 0.4 0.0% 90.6% 84.9%

China, Hong Kong SAR 0.1 Not applicable 100.0% 85.7% 0.0 Not applicable - -

China, Macao SAR 1.5 Not applicable 100.0% 100.0% 1.8 Not applicable 0.0% 0.0%

Japan 0.2 0.0% Insufficient data Insufficient data 0.0 0.0% Insufficient data Insufficient data

Lao People's Democratic Republic 4.0 50.0% 78.2% 80.0% 0.7 16.7% 30.0% 93.3%

Malaysia 14.5 87.5% 87.2% 97.1% 1.9 50.0% 54.8% 83.2%

Mongolia 3.0 22.7% 100.0% 100.0% 0.0 - - -

New Zealand 3.5 60.0% Insufficient data Insufficient data 1.5 0.0% Insufficient data Insufficient data

Papua New Guinea 1.4 20.0% 82.1% 93.3% 0.1 5.0% 100.0% 100.0%

Philippines 1.0 11.1% 43.3% 49.2% 0.3 0.0% 31.4% 55.7%

Republic of Korea 0.6 0.0% 61.5% 95.7% 0.2 0.0% 28.6% 100.0%

Singapore 0.3 Not applicable 61.8% 76.5% 0.0 Not applicable - -

Viet Nam 0.4 6.3% 30.2% 43.3% 0.0 0.0% 0.0% 7.0%

Pacific island countries and areas4 4.7 5.0% Insufficient data Insufficient data 0.7 0.0% Insufficient data Insufficient data

Western Pacific Region 17.8 27.1% 87.4% 87.2% 0.4 5.4% 73.7% 78.4%Green Reached or surpassed target

Yellow Nearly reached target: 1.00–1.99 for non-measles suspected case rate; 10.1–25% for percent clinically confirmed cases; 60–79% for other indicators

Red Substantially below target

Country/area

2020

Second level units with≥ 2 discarded cases per

100 000 pop [annualized]1

Suspected cases with adequate investigation

Suspected cases with adequate specimens for laboratory confirmation 2

≥ 80% ≥ 80% ≥ 80%

2021

Second level units with≥ 2 discarded cases per

100 000 pop [annualized]1

Suspected cases with adequate investigation

Suspected cases with adequate specimens for laboratory confirmation 2

≥ 80% ≥ 80% ≥ 80%

1 This indicator is not applicable for countries which have no second-level administrative units2 Adequate specimen defined as blood specimen collected within 28 days of rash onset or other specimen (throat swab, nasopharyngeal swab, cerebrospinal fluid, urine) collected within 5 days of rash onset; excludes epidemiologically-linked cases.3 Reports only confirmed cases4 Surveillance performance indicators refer to all the Pacific island countries and areas as one epidemiological block; each country is considered as second level unit

5

Table 5. Rubella case classification and incidence by country and area, WHO Western Pacific Region, 2017–2021 as of 20 February 2021

Clinically compatible

casesLab Epi-linked

Australia - - - - - - - - 0.00 - - - - - - - - -

Brunei Darussalam 0 0.0 0 0.0 0 0.0 0 0.0 0.00 0 - - - - - - - -

Cambodia 7 0.4 3 0.2 30 1.8 38 2.3 0.00 101 0 49 0 0 0 0 0.0 -

China 1 601 1.1 3 935 2.8 32 568 22.9 2 202 1.5 0.00 690 142 494 28 26 0 54 0.4 -

China, Hong Kong SAR 1 0.1 11 1.5 48 6.4 4 0.5 0.00 0 - - - - - - - -

China, Macao SAR 0 0.0 1 1.6 78 121.5 3 4.6 0.00 1 0 1 0 0 0 0 0.0 -

Japan3 5 0.0 68 0.5 2 394 18.9 99 0.8 0.00 9 0 3 0 2 0 2 0.2 -

Lao People's Democratic Republic 12 1.7 15 2.1 11 1.6 22 3.1 0.00 30 25 4 0 0 0 0 0.0 -

Malaysia 113 3.6 175 5.6 111 3.4 93 2.8 0.00 158 94 63 0 1 0 1 0.4 -

Mongolia 13 4.2 1 0.3 2 0.6 0 0.0 0.00 0 - - - - - - - -

New Zealand - - - - 1 0.2 - - 0.00 6 0 6 0 0 0 - - -

Papua New Guinea 1 0.1 1 0.1 5 0.6 1 0.1 0.00 1 0 1 0 0 0 0 0.0 -

Philippines 448 4.3 152 1.4 198 1.8 382 3.5 0.00 70 0 67 0 3 0 3 0.3 -

Republic of Korea 2 0.0 0 0.00 8 0.2 2 0.0 0.00 17 0 11 0 0 0 0 0.0 -

Singapore 3 0.5 16 2.8 7 1.2 10 1.7 0.00 0 - - - - - - - -

Viet Nam 126 1.3 102 1.1 85 0.9 135 1.4 0.00 71 1 1 0 0 0 0 0.0 -

Pacific island countries and areas2 4 1.2 0 0.0 0 0.0 0 0.0 0.00 2 0 2 0 0 0 0 0.0 -

Fiji 4 4.6 0 0.0 0 0.0 0 0.0 0.00 2 0 2 0 0 0 0 0.0 -

New Caledonia 0 0.0 0 0.0 0 0.0 - - 0.00 0 - - - - - - - -

Solomon Islands 0 0.0 - - - - - - 0.00 0 - - - - - - - -

Vanuatu - - - - - - - - 0.00 0 - - - - - - - -

Western Pacific Region 2 336 1.2 4 480 2.3 35 546 18.5 2 991 18.6 0.00 1 156 262 702 28 32 0 60 0.4 -1 United Nations, Department of Economic and Social Affairs, Population Division World Population Prospects 2019 revision Green <1 confirmed measles case / 1 000 000 population

2 Classification is provisional based on laboratory data only. Yellow 1–9.9 confirmed measles case / 1 000 000 population

3 Rubella cases are cases reported as suspected measles cases that were identified as rubella laboratory confirmed cases during the investigation. This represents a small proportion of a large number of rubella cases occurring in Japan during 2018 Red >= 10 confirmed cases / 1 000 000 population

"-" No data Gray No data

Total confirmed

and clinically compatible

Country/areaTotal

confirmed and clinically compatible

Rubella incidence per 1 million pop.

20202017


2018 2019

Total confirmed


Total confirmed




2021

Population (in millions)

1

Investigated for rubella

Pending classification

Discarded cases

Rubella casesTotal

confirmed and clinically compatible

Annualized Rubella

incidence per

1 million pop.

Congenital rubella

syndrome

6

Table 6A. Measles and rubella laboratory testing, WHO Western Pacific Region, 2020

No. No. % No. %No.

receivedNo. (+)

No. of samples tested

No. of isolates


No. (+) No. No. % No. %

Australia VIDRL 21 21 20 0 - - - - 0 - - 3 0 21 20 20 0 - - - -

Brunei Darussalam DLS 19 19 19 19 0 0% 0 0% 0 - 95.8 0 - 0 - 0 19 0 0% 0 0%

Cambodia NIPH 2 595 2 595 2 595 2 564 369 14% 0 0% 31 1 94.2 0 - 0 - 362 2 077 18 1% 0 0%

China CCDC - - - - - - - - 0 - 95.8 - - - - - - - - - -

China, Hong Kong SAR PHLC 427 427 369 332 3 1% 3 1% 0 - 96.3 0 - 111 0 3 196 6 3% 2 1%

China, Macao SAR PHL 82 82 70 70 5 7% 1 1% 0 - 100.0 2 0 19 0 5 70 2 3% 0 0%

Japan NIID 835 811 511 76 10 13% 26 34% 0 - - 0 - 253 4 11 118 63 53% 22 19%

Lao People's Democratic Republic NCLE 271 271 271 271 37 14% 14 5% 0 - 70.6 0 - 0 - 36 270 15 6% 9 3%

Malaysia NPHL 10 456 10 456 6 900 6 374 625 10% 145 2% 0 - 88.2 1 331 0 0 - 625 5 416 301 6% 99 2%

Mongolia NCCD 97 97 97 97 0 0% 0 0% 0 - 100.0 0 - 0 - 0 97 0 0% 0 0%

New Zealand CHL 79 79 76 4 1 25% 0 0% 0 - 75.0 0 - 75 7 7 3 0 - 0 -

Papua New Guinea CPHL 135 135 134 134 7 5% 1 1% 0 - 66.4 0 - 0 - 7 134 2 1% 3 2%

Philippines RITM 2 787 2 579 2 538 2 569 1 064 41% 69 3% 8 1 95.5 0 - 185 54 1 108 1 514 417 28% 35 2%

Republic of Korea KCDC 705 705 465 315 24 8% 14 4% 0 - 88.8 0 - 293 14 31 185 64 35% 8 4%

Singapore NPHL 344 344 332 23 2 9% 1 4% 0 - 87.0 12 1 294 10 13 23 0 0% 0 0%

Viet Nam national lab (Northern) NIHE 99 99 99 99 58 - 0 - 0 - - 0 - 0 - 58 34 3 - 2 -

Viet Nam national lab (Southern) PI 760 760 760 760 462 61% 7 1% 0 - - 0 - 0 - 462 255 26 10% 5 2%

Viet Nam subnational lab (Central) PI 30 30 30 30 19 - 0 - 0 - - 0 - 0 - 19 28 1 - 0 0%

Viet Nam subnational lab (Highland) IHE 1 1 1 1 1 100% 0 0% 0 - - 0 - 0 - 1 0 - - - -

Fiji FCCDC 214 202 202 201 5 2% 10 5% 0 - - 0 - 2 0 5 112 0 0% 3 3%

Total 19 957 19 713 15 489 13 939 2 692 19% 291 2% 39 2 90.8 1 348 1 1 253 109 2 773 10 551 918 9% 188 2%

"-" No data

Country/area Laboratory

Measles and rubellaMeasles Rubella

Serology Virus detection

Total number of

lab confirmed

cases

Serum and blood (includes DBS)Serum Blood

% of samples

with results ≤4

days

Measles Virus isolation/ detection

(swab, urine and others)

Measles Reverse

Transcription- Polymerase Chain

Reaction

Total number

of samples received

Total number

of samples tested

Total number of cases tested

Samples tested for

measles IgMMeasles IgM (+)

Measles IgM equiv

DBS samples Samples

tested for rubella IgM

Rubella IgM (+)Rubella

IgM equiv

7

Table 6B. Measles and rubella laboratory testing, WHO Western Pacific Region, 2021 as of 20 February 2021

No. No. % No. %No.

receivedNo. (+)


No. of isolates


No. (+) No. No. % No. %

Australia VIDRL 0 - - 0 - - - - - - - 0 - 0 - 0 0 - - - -

Brunei Darussalam DLS 0 - - 0 - - - - - - - 0 - 0 - 0 0 - - - -

Cambodia NIPH 49 49 49 49 3 6% 0 0% 0 - 63.4 0 - 0 - 3 49 0 0% 0 0%

China CCDC - - - - - - - - - - - - - - - - - - - -

China, Hong Kong SAR PHLC 30 30 24 26 0 0% 0 0% 0 - 95.8 0 - 4 0 0 15 0 0% 0 0%

China, Macao SAR PHL 4 4 4 4 0 0% 0 0% 0 - 100.0 0 - 0 - 0 4 1 25% 0 0%

Japan NIID 12 10 7 1 0 0% 1 100% 0 - - 0 - 1 0 0 3 2 67% 0 0%

Lao People's Democratic Republic NCLE 9 9 9 9 0 0% 0 0% 0 - 33.3 0 - 0 - 0 9 0 0% 0 0%

Malaysia NPHL 358 358 221 212 15 7% 4 2% 0 - 94.8 55 0 0 - 15 199 16 8% 5 3%

Mongolia NCCD 0 - - 0 - - - - 0 - - 0 - 0 - 0 0 - - - -

New Zealand CHL 0 - - 0 - - - - - - - 0 - 0 - 0 0 - - - -

Papua New Guinea CPHL - - - - - - - - - - - - - - - - - - - - -

Philippines RITM 53 43 43 43 2 5% 0 0% 0 - 100.0 0 - 10 0 2 40 3 8% 1 3%

Republic of Korea KCDC 28 28 16 5 0 0% 0 0% - 88.9 0 - 10 1 1 8 5 63% 1 13%

Singapore NPHL 26 26 26 3 0 0% 0 0% 0 - 100.0 0 - 23 0 0 3 0 0% 0 0%

Viet Nam national lab (Northern) NIHE 57 0 0 0 - - - - 0 - - 0 - 0 - 0 0 - - - -

Viet Nam national lab (Southern) PI 13 0 0 0 - - - - 0 - - 0 - 0 - 0 0 - - - -

Viet Nam subnational lab (Central) PI 1 0 0 0 - - - - 0 - - 0 - 0 - 0 0 - - - 0%

Viet Nam subnational lab (Highland) IHE 0 - - 0 - - - - 0 - - 0 - 0 - 0 0 - - - -

Fiji FCCDC 3 3 3 3 0 0% 0 0% 0 - - 0 - 0 - 0 3 0 0% 0 0%

Total 643 560 402 355 20 6% 5 1% 0 0 90.3 55 0 48 1 21 333 27 8% 7 2%

"-" No data

Samples tested for rubella IgM

Rubella IgM (+)Rubella

IgM equivDBS samples

Total number

of samples received

Total number

of samples tested

Total number of cases tested

Samples tested for

measles IgMMeasles IgM (+)

Measles IgM equiv

Virus detection

Total number of

lab confirmed

cases

Serum and blood (includes DBS)Serum Blood

% of samples

with results ≤4

days

Measles Virus isolation/ detection

(swab, urine and others)

Measles Reverse

Transcription- Polymerase Chain

Reaction

Country/area Laboratory

Measles and rubellaMeasles Rubella

Serology

8

Figure 3. Measles genotype distribution of cases with rash onset in 2020 and 2021, WHO Western Pacific Region

Table 7. Measles genotype distribution of cases with rash onset in February 2020 to January 2021, WHO Western Pacific Region

2020 2021

B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1Australia 4 1Brunei DarussalamCambodiaChina 14 3China, Hong Kong SARChina, Macao SARJapan 1 1Lao People's Democratic RepublicMalaysiaMongoliaNew ZealandPapua New GuineaPhilippinesRepublic of Korea 2 1Singapore 2 1Viet Nam 11 1 15Pacific island countries and areas 4 4

Feb Mar SepApr Dec2020 2021

JanOct NovMay Jun Jul AugCountry/area


The boundaries and names shown and the designations used on the maps do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO Regional Office for the Western Pacific 2021. All rights reserved.

9

Figure 4. Rubella genotype distribution of cases with rash onset in 2020 and 2021, WHO Western Pacific Region

Table 8. Rubella genotype distribution of cases with rash onset in February 2020 to January 2021, WHO Western Pacific Region

2020 2021


2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J

Australia

Brunei Darussalam

Cambodia

China 5 8 3 1 9 20China, Hong Kong SAR 1 1China, Macao SAR

Japan 2 5 3Lao People's Democratic Republic

Malaysia

Mongolia

New Zealand

Papua New Guinea

Philippines

Republic of Korea 1Singapore

Viet Nam

Pacific island countries and areas

Dec

2020 2021

NovApr JanMar May Jun Jul Aug Sep OctFebCountry/area

The boundaries and names shown and the designations used on the maps do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO Regional Office for the Western Pacific 2021. All rights reserved.

Table 9A. Completeness and timeliness of epidemiologic reporting, WHO Western Pacific Region, 2019—2021

Table 9B. Completeness and timeliness of laboratory reporting, WHO Western Pacific Region, 2019—2021

Vaccine-Preventable Diseases and Immunization Regional Office for the Western Pacific

World Health Organization

P.O. Box 2932, 1000 Manila, PhilippinesTel. No. (63 2) 85288001

Fax No. (63 2) 85211036, 85260279Please send your comments and monthly data before the 10th of the month to: [email protected]

More detailed information available in theRegional and country profile of measles elimination

Jan

Australia 100% 92% 100% 92% 03 Feb 100% 100%

Brunei Darussalam 100% 100% 100% 100% 06 Feb 100% 100%

Cambodia 100% 100% 100% 100% 10 Feb 100% 100%

China 100% 33% 100% 100% 18 Feb 100% 0%

China, Hong Kong SAR 92% 92% 100% 100% 05 Feb 100% 100%

China, Macao SAR 100% 100% 100% 100% 08 Feb 100% 100%

Japan 100% 67% 92% 25% 07 Feb 100% 100%

Lao People's Democratic Republic 100% 100% 100% 100% 10 Feb 100% 100%

Malaysia 100% 83% 100% 92% 09 Feb 100% 100%

Mongolia 100% 100% 100% 100% 10 Feb 100% 100%

New Zealand 100% 100% 100% 100% 05 Feb 100% 100%

Papua New Guinea 75% 25% 100% 83% 10 Feb 100% 100%

Philippines 67% 17% 100% 75% 08 Feb 100% 100%

Republic of Korea 92% 33% 100% 100% 10 Feb 100% 100%

Singapore 100% 100% 100% 100% 06 Feb 100% 100%

Viet Nam 92% 92% 100% 100% 10 Feb 100% 100%

Pacific island countries and areas 100% 92% 100% 100% 15 Feb 100% 100%

Completeness 95% 100% 100% 100%

Timeliness 78% 92% 94% 94%1 National measles surveillance monthly reports from January 2021. Legend: black = timely report; red = untimely report2 Completeness is defined as the number of reports received by the end of the reporting month divided by the number of expected reports for the year.

2019

Completeness 2 Timeliness 3Country

2021 1

Completeness 2 Timeliness 3

3 Countries and areas should submit reports by the 10th (or the next working day) of the following month; Pacific island countries and areas and China may report to the Regional Office by the 15th (or the next working day) of the following month.

2020

Completeness 2 Timeliness 3

Australia 100% 92% 100% 100% 03 Feb 100% 100%

Brunei Darussalam 100% 100% 100% 100% 02 Feb 100% 100%

Cambodia 100% 108% 100% 100% 10 Feb 100% 100%

China 100% 100% 100% 100% 02 Feb 100% 100%

China, Hong Kong SAR 100% 100% 100% 100% 10 Feb 100% 100%

China, Macao SAR 100% 100% 100% 100% 08 Feb 100% 100%

Japan 100% 58% 92% 25% 07 Feb 100% 100%

Lao People's Democratic Republic 100% 100% 100% 100% 10 Feb 100% 100%

Malaysia 100% 83% 100% 83% 09 Feb 100% 100%

Mongolia 100% 100% 100% 100% 10 Feb 100% 100%

New Zealand 100% 100% 100% 100% 10 Feb 100% 100%

Papua New Guinea 75% 67% 42% 42% - 0% 0%

Philippines 92% 83% 100% 92% 10 Feb 100% 100%

Republic of Korea 100% 100% 100% 92% 10 Feb 100% 100%

Singapore 100% 100% 100% 100% 06 Feb 100% 100%

Viet Nam national lab (Northern) 100% 92% 100% 100% 10 Feb 100% 100%

Viet Nam national lab (Southern) 100% 100% 100% 100% 10 Feb 100% 100%

Viet Nam subnational lab (Central) 100% 92% 100% 100% 10 Feb 100% 100%

Viet Nam subnational lab (Highland) 100% 92% 100% 100% 10 Feb 100% 100%

Fiji 100% 92% 100% 100% 15 Feb 100% 100%

Completeness 98% 97% 95% 95%

Timeliness 92% 92% 95% 95%1 National measles laboratory monthly reports from January 2021.

2 Completeness is defined as the number of reports received by the end of the reporting month divided by the number of expected reports for the year.

3 National measles and rubella laboratories should submit monthly reports by the 10th (or the next working day) of the following month.

Completeness 2 Timeliness 3Completeness 2 Timeliness 3Country/area

20202019

Completeness 2 Timeliness 32021 1

Jan

volume 15 • issue 2 • february 2021 issn 1814 3601...lao people's democratic republic 3 0.4...

Documents